Persistent astrocyte activation in the fragile X mouse cerebellum

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Fragile X Syndrome (FXS), a leading single-gene cause of autism, stems from the loss of the Fragile X mental retardation protein (FMRP).
• While FMRP is primarily neuronal, its presence in glia suggests non-neuronal cells may influence FXS pathogenesis.
• Previous studies noted reduced oligodendrocyte precursor cells and delayed myelination in the cerebellum of Fmr1 knockout mice.

Purpose of the Study:

• To investigate the status of astrocytes and microglia in the cerebellum of Fmr1 knockout mice during development and adulthood.
• To understand the role of glial cells in the neuropathology of Fragile X Syndrome.

Main Methods:

• Quantitative western blotting and immunocytochemistry were employed.
• Cerebellar tissues from Fmr1 knockout and wild-type mice were analyzed at various developmental and adult stages.

Main Results:

• Increased glial fibrillary acidic protein (GFAP) expression, an astrocyte marker, was observed in Fmr1 knockout mice from the second postnatal week into adulthood.
• Elevated levels of Tumor Necrosis Factor Receptor 2 (TNFR2) and Leukemia Inhibitory Factor (LIF) were detected in young Fmr1 knockout mice.
• Adult Fmr1 knockouts showed increased TNFR2 and S100β (glial marker) but normal LIF levels compared to wild-type.
• No evidence of microglial activation or neuroinflammation was found at any age.

Conclusions:

• Fmr1 knockout mice exhibit atypical astrogliosis without microglial activation in the cerebellum.
• Enhanced TNFR2 and LIF expression in young Fmr1 knockout mice may represent a compensatory mechanism for delayed myelination.
• These findings highlight the contribution of glial cell alterations to the cerebellar phenotype in Fragile X Syndrome.